Loading clinical trials...

Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients | Clinical Trials | Clareo Health

COMPLETED

Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients

A Survey of the Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients

NCT02374411•Edward Hospital

View on ClinicalTrials.gov

Summary

The goal of this survey of international HIPEC (Hyperthermic Intraperitoneal Chemotherapy) surgeons is to determine their knowledge of and attitudes towards the nutritional support needs of HIPEC patients and what their practice patterns are with this patient population.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Surgeon trained in and performing the HIPEC procedure

Exclusion Criteria

•Not performing the HIPEC procedure

Locations (1)

Edward Hospital

Naperville, Illinois, United States

Key Dates

Start Date

September 1, 2014

Primary Completion Date

March 1, 2015

Completion Date

March 1, 2015

Last Updated

February 8, 2017

Enrollment

ACTUAL participants

Conditions

Pseudomyxoma PeritoneiAppendiceal NeoplasmsPancreatic NeoplasmsNeoplasm MetastasisAdenocarcinomaSarcomaUterine Neoplasms

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

NCT06885697

MesotheliomaNeoplasms+6 more

View study

RECRUITING

Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD

NCT07139236

Pancreatic NeoplasmsPancreatic Fistula

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 8, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients

Inclusion Criteria

Exclusion Criteria

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia

Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer